Anbio Biotechnology (NNNN) stock
NNNNNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 11/30
$3.60−0.05 (-1.37%)
Close on Nov 18, 2026Market cap $518.01MP/E 24.5Yield –
Anbio Biotechnology profit margin
Profit margin (net margin) is net income as a percentage of revenue.
For fiscal 2025 it was 74.1%, against 29.0% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 74.1% | +45.1 |
| FY2024 | Dec 31, 2024 | 29.0% | −4.6 |
| FY2023 | Dec 31, 2023 | 33.6% | −8.9 |
| FY2022 | Dec 31, 2022 | 42.5% | – |
See a number that looks wrong?